The peptide initiates the cascade, but the cascade itself becomes self-sustaining for a defined period through feedback loops and secondary messenger systems
BPC-157 , (VEGF) -1 (EGR-1)
For more details, check outGuys and St Thomas NHS
Although peptides like BPC 157 are not yet FDA-approved, we are seeing promising results in patients seeking relief from a variety of injuries, chronic pain, and inflammation
Berdoukas V, Farmaki K, Carson S, Wood J, Coates T
Such an effect is also associated with antiplatelet agents, for instance, ticlopidine and clopidogrel, and chemotherapeutic agents (e.g., mitomycin C and gemcitabine